BioCentury | Jun 9, 2017
Company News

Management tracks

...Silence Therapeutics plc (LSE:SLN) named Torsten Hoffmann COO. He was CSO and managing director at Proteros biostructures GmbH...
BioCentury | Dec 2, 2016
Company News

Proteros, Merck deal

...Proteros and Merck partnered to develop small molecules against an epigenetic target to treat cancer. Proteros...
...details. Last October, the companies partnered to develop small molecules against a separate epigenetic target. Proteros biostructures GmbH...
...Martinsried, Germany Merck & Co. Inc. (NYSE:MRK), Kenilworth, N.J. Business: Cancer Jaime De Leon Merck & Co. Inc. Proteros biostructures GmbH epigenetics...
BioCentury | Apr 14, 2016
Emerging Company Profile

Thinking about HDAC2

...focus: Neurology Clinical status: Preclinical Founded: 2013 by Marty Jefson, Ankit Mahadevia, Atlas Venture and Proteros biostructures GmbH...
BioCentury | Jul 1, 2015
Company News

Management tracks

...of legal at Actavis plc , now known as Allergan plc (NYSE:AGN). Structural biology company Proteros biostructures GmbH...
BioCentury | Jun 2, 2014
Finance

Epigenetic risk management

...Rodin in 2013 with an undisclosed seed round and a partnership with fellow founding investor Proteros biostructures GmbH...
...Rodin CSO Martin Jefson told BioCentury the seed round enabled the biotech to work with Proteros'...
BioCentury | May 19, 2014
Company News

Proteros management update

Proteros biostructures GmbH , Martinsried, Germany Business: Computational chemistry/biology, Supply/Service Hired: Michael Grau as CFO, formerly group CFO and chief compliance officer of Correvio LLC, which Cardiome Pharma Corp. acquired Promoted: Peter Reinemer to COO from...
BioCentury | Oct 17, 2013
Strategy

Clinical takeoff for new epigenetic targets

...notable deals include GlaxoSmithKline plc taking out Cellzome AG and Rodin Therapeutics Inc.'s partnership with Proteros biostructures GmbH...
...with Proteros, J&J's Janssen Research & Development LLC unit and the pharma's Boston Innovation Center; Proteros...
...chemical optimization Rodin has undisclosed financing from Atlas Venture and Johnson & Johnson Development Corp.; Proteros...
BioCentury | Aug 1, 2013
Targets & Mechanisms

Activating memory

...very much at the heart of what we're doing," said Booth. Rodin is partnered with Proteros biostructures GmbH...
...Mentioned Atlas Venture , Cambridge, Mass. Centre National de la Recherche Scientifique , Strasbourg, France Proteros biostructures GmbH...
BioCentury | Jul 22, 2013
Strategy

Getting up to speed

...small molecule epigenetic modulators to treat CNS disorders, including Alzheimer's disease (AD). Founding Rodin shareholder Proteros biostructures GmbH...
...N.Y. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Massachusetts Institute of Technology (MIT), Cambridge, Mass. Proteros biostructures GmbH...
BioCentury | Jul 1, 2013
Company News

Proteros, Rodin Therapeutics, Vedanta, J&J, Icahn School of Medicine at Mount Sinai Hospital deal

...including Alzheimer's disease (AD). Founding shareholder Proteros granted Rodin access to Proteros' structural biology platform. Proteros...
...centers are in London and California (see BioCentury Sept. 24, 2012 & June 10, 2013). Proteros biostructures GmbH...
Items per page:
1 - 10 of 26
BioCentury | Jun 9, 2017
Company News

Management tracks

...Silence Therapeutics plc (LSE:SLN) named Torsten Hoffmann COO. He was CSO and managing director at Proteros biostructures GmbH...
BioCentury | Dec 2, 2016
Company News

Proteros, Merck deal

...Proteros and Merck partnered to develop small molecules against an epigenetic target to treat cancer. Proteros...
...details. Last October, the companies partnered to develop small molecules against a separate epigenetic target. Proteros biostructures GmbH...
...Martinsried, Germany Merck & Co. Inc. (NYSE:MRK), Kenilworth, N.J. Business: Cancer Jaime De Leon Merck & Co. Inc. Proteros biostructures GmbH epigenetics...
BioCentury | Apr 14, 2016
Emerging Company Profile

Thinking about HDAC2

...focus: Neurology Clinical status: Preclinical Founded: 2013 by Marty Jefson, Ankit Mahadevia, Atlas Venture and Proteros biostructures GmbH...
BioCentury | Jul 1, 2015
Company News

Management tracks

...of legal at Actavis plc , now known as Allergan plc (NYSE:AGN). Structural biology company Proteros biostructures GmbH...
BioCentury | Jun 2, 2014
Finance

Epigenetic risk management

...Rodin in 2013 with an undisclosed seed round and a partnership with fellow founding investor Proteros biostructures GmbH...
...Rodin CSO Martin Jefson told BioCentury the seed round enabled the biotech to work with Proteros'...
BioCentury | May 19, 2014
Company News

Proteros management update

Proteros biostructures GmbH , Martinsried, Germany Business: Computational chemistry/biology, Supply/Service Hired: Michael Grau as CFO, formerly group CFO and chief compliance officer of Correvio LLC, which Cardiome Pharma Corp. acquired Promoted: Peter Reinemer to COO from...
BioCentury | Oct 17, 2013
Strategy

Clinical takeoff for new epigenetic targets

...notable deals include GlaxoSmithKline plc taking out Cellzome AG and Rodin Therapeutics Inc.'s partnership with Proteros biostructures GmbH...
...with Proteros, J&J's Janssen Research & Development LLC unit and the pharma's Boston Innovation Center; Proteros...
...chemical optimization Rodin has undisclosed financing from Atlas Venture and Johnson & Johnson Development Corp.; Proteros...
BioCentury | Aug 1, 2013
Targets & Mechanisms

Activating memory

...very much at the heart of what we're doing," said Booth. Rodin is partnered with Proteros biostructures GmbH...
...Mentioned Atlas Venture , Cambridge, Mass. Centre National de la Recherche Scientifique , Strasbourg, France Proteros biostructures GmbH...
BioCentury | Jul 22, 2013
Strategy

Getting up to speed

...small molecule epigenetic modulators to treat CNS disorders, including Alzheimer's disease (AD). Founding Rodin shareholder Proteros biostructures GmbH...
...N.Y. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Massachusetts Institute of Technology (MIT), Cambridge, Mass. Proteros biostructures GmbH...
BioCentury | Jul 1, 2013
Company News

Proteros, Rodin Therapeutics, Vedanta, J&J, Icahn School of Medicine at Mount Sinai Hospital deal

...including Alzheimer's disease (AD). Founding shareholder Proteros granted Rodin access to Proteros' structural biology platform. Proteros...
...centers are in London and California (see BioCentury Sept. 24, 2012 & June 10, 2013). Proteros biostructures GmbH...
Items per page:
1 - 10 of 26